AVALYN PHARMA
Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for the treatment of IPF, provides additional pipeline candidates for IPF, improve the care and outcomes of severe respiratory diseases, and develop novel inhaled therapeutics. Avalyn Pharma was established in 2011 and is headquartered in Seattle, Washington.
AVALYN PHARMA
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2011-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.avalynpharma.com
Total Employee:
11+
Status:
Active
Total Funding:
272.5 M USD
Technology used in webpage:
Font Awesome CrUX Dataset CrUX Top 10m Ninja Forms
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Mark W. Surber Founder and CSO @ Avalyn Pharma
Founder and CSO
2017-03-01
Lyn Baranowski CEO @ Avalyn Pharma
CEO
Melissa Rhodes Chief Operating Officer @ Avalyn Pharma
Chief Operating Officer
2023-09-01
Bruce Montgomery CEO @ Avalyn Pharma
CEO
2017-03-01
Douglas Carlson Chief Financial Officer and Chief Business Officer @ Avalyn Pharma
Chief Financial Officer and Chief Business Officer
2024-05-01
Founder
Investors List
Novo Holdings
Novo Holdings investment in Series C - Avalyn Pharma
F-Prime Capital
F-Prime Capital investment in Series C - Avalyn Pharma
SR One
SR One investment in Series C - Avalyn Pharma
Norwest Venture Partners
Norwest Venture Partners investment in Series C - Avalyn Pharma
RiverVest
RiverVest investment in Series C - Avalyn Pharma
Rock Springs Capital
Rock Springs Capital investment in Series C - Avalyn Pharma
Perceptive Advisors
Perceptive Advisors investment in Series C - Avalyn Pharma
Surveyor Capital
Surveyor Capital investment in Series C - Avalyn Pharma
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - Avalyn Pharma
Vida Ventures
Vida Ventures investment in Series C - Avalyn Pharma
Key Employee Changes
Official Site Inspections
http://www.avalynpharma.com Semrush global rank: 3.04 M Semrush visits lastest month: 5.26 K
- Host name: 170.251.121.34.bc.googleusercontent.com
- IP address: 34.121.251.170
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avalyn Pharma"
Avalyn Pharma - Crunchbase Company Profile & Funding
Contact Email info@avalynpharma.com Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for …See details»
Overview - Avalyn Pharma Inc
Here at Avalyn, diversity, equity, and inclusion are vital elements of our culture, and we work hard to ensure all voices are welcomed, heard, and respected. We value the diversity of our team, …See details»
News - avalynpharma.com
Nov 6, 2023 Jim Bishop joined Avalyn in October 2023 as senior vice president, business operations, and he is responsible for corporate strategy and overseeing multiple functions …See details»
Avalyn Pharma - LinkedIn
Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases.See details»
Avalyn Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.avalynpharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
Avalyn Pharma Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Avalyn Pharma. Use the PitchBook Platform to explore the full profile.See details»
Avalyn Pharma - Craft
Seattle, WA HQ. United States. 701 Pike St #1500. San Diego, CA. United States. 2251 San Diego Ave suite b - 111See details»
Avalyn Pharma Appoints Lyn Baranowski Chief …
Oct 17, 2022 More information can be found at www.avalynpharma.com. Contacts. Investors: Marc Schneebaum Chief Financial Officer, Avalyn Pharma, Inc mschneebaum@avalynpharma.com.See details»
Avalyn Raises $175 Million in Oversubscribed Series C Financing to ...
Sep 27, 2023 The Series C financing was co-led by Perceptive Xontogeny Venture Funds, SR One, and Eventide Asset Management, which were joined by new investors, Vida Ventures, …See details»
Avalyn Pharma Appoints Business Operations Leader, Melissa
Seattle, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies...See details»
Board of Directors - Avalyn Pharma Inc
Avalyn is developing inhaled formulations of approved medications to treat rare respiratory diseases Our initial focus is on the treatment of Interstitial Lung Diseases, including Pulmonary …See details»
Avalyn Pharma Reports Data After One Year of Treatment in …
Seattle, April 11, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary …See details»
Avalyn Pharma Expands Executive Team with Appointment of
Seattle, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies...See details»
Doug Carlson - Avalyn Pharma Inc
Doug Carlson is the chief financial officer and chief business officer of Avalyn Pharma. Mr. Carlson brings over 23 years of experience with a multi-disciplinary background in corporate …See details»
Avalyn Pharma Made Corporate and Clinical Presentations at ATS …
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary …See details»
Avalyn Pharma Reports Results of Phase 1 Study of AP02 in …
Mar 31, 2023 More information can be found at www.avalynpharma.com. Posted Under. Treatment. Tagged. idiopathic pulmonary fibrosis. ... CheckOrphan is a non-profit organization …See details»
Overview - Avalyn Pharma Inc
Therapeutic: AP01 (inhaled pirfenidone), in clinical development as a potential inhaled treatment for progressive pulmonary fibrosis (PPF) Trial Status: Actively recruiting Trial Information: The …See details»
Avalyn Pharma Reports Data After One Year of Treatment in
Seattle, April 11, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat...See details»
News - Avalyn Pharma Inc
Nov 14, 2024 September 8, 2024. Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc …See details»